Breaking News

AstraZeneca Re-Launches Phase 3 COVID-19 Vaccine Study

September 12, 2020 • 10:27 am CDT

On September 12, 2020, AstraZeneca announced 'that phase 3 clinical trials for the AZD1222 coronavirus vaccine candidate have resumed in the United Kingdom following confirmation by the Medicines Health Regulatory Authority ... that it was safe to do so.'

Medical Review by